Clinical Trials Sponsored by DUSA Pharmaceuticals, Inc

Total 5554 results

Teva Pharmaceuticals USA

Completed

Topiramate 25 mg Capsules Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Topiramate 25 mg Capsule Mixed With Applesauce Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Azithromycin 600 Mg Tablets, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Leflunomide 20 mg Tablets, Non-Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Venlafaxine 25 mg Tablets Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Carvedilol (25 mg) in 24 Fed, Healthy, Adult Subjects

Healthy

United States
Teva Pharmaceuticals USA

Completed

Azithromycin 600 Mg Tablets, Fed

Healthy

United States
Teva Pharmaceuticals USA

Completed

Leflunomide 20 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Clarithromycin 500 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Meloxicam 15 mg Tablets Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Lamotrigine 25 mg Chewable Tablets, Fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Bioequivalence Study of 200 mg Lamotrigine Tablet Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Granisetron 1 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Levetiracetam 750 mg Tablets Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Levetiracetam 750 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Glimepiride 4 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

15 mg Mirtazapine Orally Disintegrating Tablets, Non-Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

15 mg Mirtazapine Orally Disintegrating Tablets, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Metformin ER 750 mg Tablets, Fed

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Divalproex Sodium 500 mg Extended Release Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Levetiracetam 1000 mg Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Ondansetron HCl Orally Disintegrating Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Levetiracetam 1000 mg Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Famciclovir 500 mg Tablets Under Fasting Conditions

Healthy

United States, Canada
Teva Pharmaceuticals USA

Completed

Cefdinir for Oral Suspension 250 mg/5mL, Non-fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefdinir Capsules 300 mg, Non-fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefdinir Capsules 300 mg, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefprozil 500 mg Tablets Under Fed Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefprozil for Oral Suspension 250 mg/5 mL, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Mycophenolate Mofetil Tablets Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Dexmethylphenidate Hydrochloride Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Zaleplon 10 mg Capsules Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Trandolapril 4 mg Tablet Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Amlodipine 10 mg Tablets Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions.

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women

Healthy

Germany
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2)

Chronic HBV Infection

United States, Canada
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP-938 in Healthy Subjects

RSV Infection

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP 305 in Healthy Subjects and Subjects With Presumptive NAFLD

Presumptive NAFLD

United States
Endo Pharmaceuticals
Teva Pharmaceuticals USA

Completed

A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering

Stuttering

United States
University of Kansas
DUSA Pharmaceuticals, Inc.

Completed

A Small Clinical Study: Photodynamic Therapy to Treat Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States
Jazz Pharmaceuticals
Otsuka Pharmaceutical Development & Commercialization, Inc.

Completed

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer (SPRAY III)

Pain | Advanced Cancer

United States, Germany, United Kingdom, Mexico, Poland, Romania, Bulgaria, Czechia, Hungary, Puerto Rico

Clinical Trials Sponsored by DUSA Pharmaceuticals, Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations